Literature DB >> 14522415

Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.

Braim M Rahel1, Frank L J Visseren, Maarten-Jan Suttorp, Thijs H W Plokker, Johannes C Kelder, Bartelt M de Jongh, K Paul Bouter, Rob J A Diepersloot.   

Abstract

OBJECTIVE: In this study we evaluate the value of baseline concentrations of acute-phase reactants on prognosis after percutaneous coronary intervention (PCI).
METHODS: Blood samples were drawn immediately before PCI to measure baseline concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), lipoprotein(a) (Lp(a)), and fibrinogen. Follow-up data were collected at 8 months. Repeat PCI, CABG, myocardial infarction, and death were recorded as major adverse clinical events (MACE). Furthermore the recurrence of angina pectoris was noted.
RESULTS: The study included 600 consecutive patients after a successful PCI. Sixty-four percent of the patients were stented. The mean age was 61.6 years and 68.9% were male. CRP levels were significantly higher in patients who were to have repeat angina as compared with those who were not (P=0.0322). IL-6 levels were not correlated with angina or MACE. Lp(a) and fibrinogen concentrations were both significantly related to MACE (P=0.0337 and P=0.0253, respectively).
CONCLUSION: Our study clearly supports the role of inflammation in restenosis after PCI as measured in statistically higher levels of Lp(a) and fibrinogen in patients with MACE and CRP in patients with repeat angina.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522415     DOI: 10.1016/s0008-6363(03)00355-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  Periprocedural plasma fibrinogen levels and coronary stent outcome.

Authors:  S Kavitha; M G Sridhar; S Satheesh
Journal:  Indian Heart J       Date:  2015-08-05

2.  Monocyte Chemoattractant Protein-1 Levels and Postangioplasty Restenosis of Arteriovenous Fistulas.

Authors:  Chih-Cheng Wu; Tsung-Yan Chen; Mu-Yang Hsieh; Lin Lin; Chung-Wei Yang; Shao-Yuan Chuang; Der-Cheng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-26       Impact factor: 8.237

3.  Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.

Authors:  Alessandro Lupi; Gioel Gabrio Secco; Andrea Rognoni; Lidia Rossi; Maurizio Lazzero; Federico Nardi; Roberta Rolla; Giorgio Bellomo; Angelo Sante Bongo; Carlo Di Mario
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

4.  Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design.

Authors:  Bart A N Verhoeven; Evelyn Velema; Arjan H Schoneveld; Jean Paul P M de Vries; Peter de Bruin; Cees A Seldenrijk; Dominique P V de Kleijn; Els Busser; Yolande van der Graaf; Frans Moll; Gerard Pasterkamp
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.

Authors:  Yaobo Yang; Fangfang Ge; Jing Shen; Jianbo Song; Jiapei Xie; Jiangshuai Qu; Xinzu Mao; Zhaocheng Kuang; Xiang Wang; Yejun Wu; Shenghai Wang; Liang Xiao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

6.  Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention.

Authors:  Hui-Hui Liu; Ye-Xuan Cao; Jing-Lu Jin; Hui-Wen Zhang; Qi Hua; Yan-Fang Li; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Rui-Xia Xu; Xie-Hui Chen; Jian-Jun Li
Journal:  J Am Heart Assoc       Date:  2020-01-30       Impact factor: 5.501

7.  A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.

Authors:  Fatih Mehmet Ucar
Journal:  BMC Cardiovasc Disord       Date:  2016-10-03       Impact factor: 2.298

8.  Myoblast transplantation improves cardiac function after myocardial infarction through attenuating inflammatory responses.

Authors:  Bo Wang; Likui Zhang; Hao Cao; Junqi Yang; Manya Wu; Yali Ma; Huimin Fan; Zhenzhen Zhan; Zhongmin Liu
Journal:  Oncotarget       Date:  2017-05-27

9.  Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.

Authors:  Jing Gao; Hai-Bo Wang; Jian-Yong Xiao; Min Ren; Kathleen Heather Reilly; Yu-Ming Li; Yin Liu
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

10.  Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation.

Authors:  Hengyi Liang; Yuqi Cui; Haoran Bu; Hang Liu; Pengcheng Yan; Lianqun Cui; Liming Chen
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.